lorazepam · Almatica · NDA 214826
Loreev Xr
Earliest generic entry, as listed · earliest of 4 marketed strengths
8 Jan 2034
Blocked by patent: US 8999393.
Listed patents · 1 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 8999393 | product, use U-3210 | 8 Jan 2034 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 4
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 214826 · 001 · RLD | capsule, extended release, oral | 1MG | 8 Jan 2034 |
| 214826 · 002 · RLD | capsule, extended release, oral | 2MG | 8 Jan 2034 |
| 214826 · 003 · RLD | capsule, extended release, oral | 3MG | 8 Jan 2034 |
| 214826 · 004 · RLD | capsule, extended release, oral | 1.5MG | 8 Jan 2034 |